Bacilli vigorously secrete proteins into the extracellular environment, and are therefore used in industry for the bulk production of enzymes such as proteinases and amylases. Studies on the mechanism of protein translocation in these Gram-positive bacteria have been hampered by the lack of an in vitro system. To establish such a system for Bacillus subtilis, everted membranes were isolated from a strain deficient in the alkaline and neutral protease. Translocation-competent membrane vesicles were obtained only when a broad range proteinase-inhibitor cocktail was used during membrane isolation. This method efficiently prevented proteolysis of SecY, one of the core integral membrane components of the preprotein translocase. Translocation of the urea-denatured precursor of the Bacillus licheniformis A-amylase, preAmyL, and B. subtilis alkaline phosphatase, prePhoB, into the B. subtilis membrane vesicles require the B. subtilis SecA protein and are driven by ATP hydrolysis and the proton-motive force. These studies establish an authentic in vitro translocation system for protein secretion in B. subtilis.
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In Escherichia coli and other Gram-negative bacteria, the outer membrane is the main barrier for protein export into the external medium. Proteins can be excreted in the medium either via a two-step reaction that involves separate translocation steps across the inner and outer membrane with the accumulation of a periplasmic intermediate [1] , or directly across both the inner and outer membrane via specific secretory systems without the accumulation of a periplasmic intermediate. In the two-step reaction, proteins are first translocated as precursors across the inner membrane via the general secretory system, while outermembrane translocation either occurs via a specific secretory system, or via a self-assembling outer-membrane-inserting subdomain that is proteolytically removed after the protein has crossed the outer membrane. In all these cases, the secretory system is rather specific for a particular (subset of) protein(s), while the general protein secretion system, the 'Sec-system', translocates proteins only into the periplasm. In contrast, Grampositive bacteria lack an outer membrane and the secretory proteins are, therefore, immediately released into the external medium once they have passed the inner membrane. Although the cell wall may act as a molecular sieve and retard protein export by ionic interactions, folded exported proteins, in general, are able to pass this barrier. For this reason, Gram-positive bacteria, in particular Bacilli, are ideal hosts for the industrial production of bulk secretory enzymes.
Bacilli are known to vigorously secrete hydrolytic and proteolytic proteins, in particular at the late log phase. However, despite their great potential and commercial utilisation for pro-tein export, little is known about the protein-translocation system in compared to the system in E. coli [2, 3] . Bacillus secretory proteins bear an amino-terminal signal sequence with a domain structure that is, to a large extent, similar to that of the E. coli signal sequences. Their signal sequences tend to be longer (by 5Ϫ7 amino acids) than those of E. coli [4] . These extensions occur in all three regions (n, h and c regions). The amino-terminus (n region) usually contains a higher instance of lysyl and arginyl residues, while the hydrophobic core (h region) is also longer than the corresponding region of E. coli signal sequences. The longer c region may reflect differences in substrate specificity of the Gram-positive signal peptidases as compared to the E. coli signal peptidase I, as cleavage occurs preferentially 7Ϫ9 residues or 3Ϫ7 residues, respectively, from the carboxyl-terminus of the h region [5] . Nevertheless, protein secretion across the membrane of B. subtilis is thought to be catalysed by a system that is homologous to the E. coli preprotein translocase [6] . In E. coli, preprotein translocation is mediated by a cytosolic chaperone, SecB, the translocation ATPase, SecA, and a large integral membrane protein complex with SecY, SecE, SecG, SecD and SecF as subunits [7] . Only SecA, SecE and SecY are essential components, whereas the other proteins add to the fidelity, and possibly to the specificity of the reaction. Many of the essential subunits of preprotein translocase of B. subtilis have been identified genetically. SecA is encoded by the divA gene [8, 9] , and was originally found in a set of mutants conditionally defective in division or unable to sporulate. The integral membrane proteins SecY [10Ϫ12] and SecE [13] were identified after nucleotide sequence analysis of the chromosomal regions that contain the ribosomal spc operon and nusG that, in E. coli, contain secY and secE, respectively. The complete sequence analysis of the B. subtilis chromosome has also revealed the presence of homologues of SecD and SecF, but not of SecB [14] . B. subtilis contains not one but multiple signal peptidases that appear to be involved in the modulation of specificity towards different secretory proteins [15] . Finally, in vivo studies have established that, in analogy to E. coli, protein export in B. subtilis requires ATP and the proton motive force as energy sources [16, 17] .
In addition to the large similarity of the secretory apparatuses of B. subtilis and E. coli, as paradigms of Gram-positive and negative bacteria, there are also some marked differences. PrsA, a protein that is membrane bound through the presence of an amino-terminal fatty acyl anchor, and itself is a secretory protein, has a profound effect on the secretion of some proteins in B. subtilis but is absent in E. coli [18, 19] . PrsA is thought to function as a prolyl-peptidyl isomerase, but in vitro its activity has not yet been demonstrated. Another point of interest is the degree of host specificity of the components of the secretory apparatus. The E. coli SecA cannot complement the B. subtilis divA mutant [20] whereas, under specific sets of conditions, the B. subtilis SecA can complement the conditionally lethal secA mutations [21Ϫ24]. Also, the E. coli and B. subtilis SecY proteins do not appear to be exchangeable [10] . Therefore, a comparison of the E. coli and B. subtilis secretory systems may reveal salient details on host and substrate specificity. Even with the wealth of in vivo and in vitro information available on the E. coli system, the differences and incompatibilities justify further studies of the mechanism of protein export in B. subtilis.
Over the last years, the advance in our knowledge on protein secretion in E. coli has been the results of integrated genetic, biochemical and enzymological investigations. A major advance has been the development of an in vitro protein translocation system based on everted inner membrane vesicles [25] and, more recently, by the use of purified preproteins and translocase components reconstituted into liposomes [26, 27] . Despite many attempts [28] , it has not yet been possible to obtain a reliable in vitro translocation system for B. subtilis. This limits the possibilities to investigate the mechanism of protein export in this organism. For the Gram-positive organism Staphylococcus carnosus, translocation into isolated membrane vesiclesof a radiolabeled precursor protein following in vitro transcription-translation has been reported [29] . This system relies on the use of S-30 cytosolic extracts that contain a multitude of cytosolic proteins and factors that may contribute in an unspecified fashion to the translocation reaction. We now report on the development of an in vitro translocation system for B. subtilis using isolated membrane vesicles of a proteinase-deficient strain, purified cytosolic molecular chaperones, and the purified precursors of the Bacillus licheniformis A-amylase and B. subtilis alkaline phosphatase. This system enables biochemical studies of the mechanism and specificity of protein secretion in the Gram-positive Bacilli.
MATERIALS AND METHODS
Bacterial strains and growth media. Strains were grown in Luria-Bertani broth or on Luria-Bertani agar unless indicated otherwise. For plasmid bearing E. coli strains, the medium was supplemented with 50 µg/ml ampicillin and 0.5 % glucose. Construction of vectors and overproduction of preAmyL was in E. coli DH5A (supE44, ∆lacU169, (80lacZ∆M15), hsdR17, recA1, endA1, gyrA96, thi-1, relA1). Membrane vesicles were prepared from B. subtilis DB104 (nprE18, aprE∆3) [30] .
Preparation of secretion components and antibodies. B. subtilis [31] and E. coli SecA [32, 33] and E. coli SecB [34] were isolated from overproducing strains as described. The B. subtilis GroESL complex was isolated from E. coli cells harboring plasmid pREP9ESL [35] . B. licheniformis anti-(A-amylase) polyclonal antibodies were kindly provided by C. Lund-Jensen and S. Jørgensen (Novo Nordisk, Copenhagen, Denmark). The mAb directed against the His 6 tag was from Dianova. A polyclonal Ab directed against a synthetic peptide corresponding to amino acid residues 417Ϫ431 of B. subtilis SecY (ESQLVKRN-YRGFMKN) was raised by Research Genetics. Complete TM protease inhibitor cocktail was purchased from Boehringer. All chemicals were from Sigma unless stated otherwise.
Construction of His 6 -tagged preAmyL and prePhoB. A vector harboring a His 6 tag was generated by ligating an oligonucleotide linker into NcoI-digested pTRC99a [36] yielding pET302 [37] . The B. licheniformis A-amylase gene was isolated from plasmid pCJ199 (Lund-Jensen, C., unpublished results) as a BspHIϪHindIII cassette, and ligated into NcoIϪHindIII-digested pET302. The resulting vector, pET436, harbors the amyL gene in-frame with the His 6 tag under the control of the Trc promoter. In the case of prePhoB, the gene was amplified by PCR from the chromosome of B. subtilis DB104 as an NcoIϪ BamHI fragment, and cloned into pET302, yielding pET461.
Expression and labelling of precursor proteins. An overnight culture of E. coli cells transformed with pET436 or pET461 was diluted 100-fold into fresh medium and grown aerobically. At mid-log phase, expression was induced with 1 mM isopropylthio-β-D-galactopyranoside and secretion of preproteins was inhibited by addition of 1 mM sodium azide [38] . After 2 h, cells were harvested by centrifugation and resuspended in cold 150 mM NaCl, 50 mM TrisCl, pH 7.5 (NaCl/Tris). Cells were broken by passing the suspension three times through a French pressure cell at 965 kPa. Inclusion bodies containing preAmyL were collected by centrifugation for 10 min at 10000ϫg, washed once with NaCl/Tris and dissolved in 6 M urea, 150 mM NaCl, 50 mM TrisCl, pH 7.5 (solution A). Debris and membrane fractions were removed by centrifugation for 60 min at 135 000ϫg. The supernatant was loaded on a HiTrap Ni ϩ -nitrilotriacetate affinity column (Pharmacia) previously equilibrated with 1 column volume of 100 mM NiCl and 10 volumes solution A. Contaminating proteins were washed from the column by a 0Ϫ80-mM (preAmyL) or 0Ϫ60-mM (prePhoB) imidazole gradient in solution A, followed by elution of the precursor protein at 500 mM imidazole. The purity of the eluted preAmyL and prePhoB was confirmed by 10% SDS/PAGE [39] and blotting onto poly(vinylidene difluoride) membranes (Millipore) using a semi-dry blotting apparatus (BioRad). Immunodetection was carried out with a polyclonal Ab raised against A-amylase or with an anti-His 6 tag mAb. Blots were developed with a chemiluminescence kit (Tropix).
Purified protein was labelled with carrier free 125 I (Radiochemical Centre) according to the following procedure : residual imidazole was removed by chromatography on a PD-10 Sephadex column (Pharmacia) using solution A. Precursor potein (100 µg; 1 mg/ml) was transferred to a Iodo-Gen-(Pierce Rockford)-coated reaction vial, and the labelling reaction was started by the addition of 200 µCi K 125 I. After 15 min incubation at 20°C, the reaction was terminated by transferring the mixture to a new vial containing dithiothreitol at 10 mM final concentration. Free iodine was removed by chromatography on a PD-10 Sephadex column which had been washed with solution A, and the protein was stored at Ϫ80°C in solution A.
Isolation of everted membrane vesicles. B. subtilis DB104 cells were grown aerobically to mid-exponential phase. Cells were harvested by centrifugation and resuspended in 50 mM potassium phosphate, pH 7.5, supplemented with Complete TM protease inhibitor cocktail according to the recommendations of the manufacturer. Everted membrane vesicles [28, 40] were prepared by passing the cell suspension through a French pressure cell three times at 965 kPa. Remaining cells and debris were removed by centrifugation for 10 min at 8000ϫg, and the membranes were collected from the supernatant by centrifugation for 60 min at 135 000ϫg. Membrane vesicles were resuspended in 50 mM potassium phosphate, pH 7.5, at a protein concentration of 25 mg/ml, and stored in liquid nitrogen. The integrity of SecY and SecA in the membranes was verified by SDS/PAGE and immunoblotting using antibodies directed against SecA [31] and a SecY synthetic peptide. Where indicated, membranes were incubated with 6 M urea, 50 mM potassium phosphate, pH 7.5, for 1 h on ice, washed three times with 50 mM potassium phosphate, pH 7.5, and stored in liquid nitrogen. For ATPase measurements, membrane vesicles were prepared in 50 mM TrisCl, pH 7.5, instead of potassium phosphate. Membranes were incubated with 6 M urea, 50 mM TrisCl, pH 7.5, for 1 h on ice, washed three times with 50 mM TrisCl, pH 7.5, and stored in liquid nitrogen.
In vitro translocation and translocation ATPase assays. In vitro translocation of 125 I-preAmyL and 125 I-prePhoB into B. subtilis membrane vesicles was essentially carried out as described for E. coli [33] . Reaction mixtures (50 µl) contained 50 mM Hepes/KOH, pH 7.5, 30 mM KCl, 0.5 mg/ml BSA, 2 mM dithiothreitol, 2 mM MgOAc, membrane vesicles (25 µg protein), 10 mM creatine phosphate and 0.5 µg creatine kinase. When indicated, 0.5 µg purified B. subtilis or E. coli SecA protein, 1.6 µg purified E. coli SecB or 20 µg purified B. subtilis GroESL were added, followed by the addition of 2 µM (or when indicated 2 mM) ATP. Reactions were started by the addition of 1 µl 125 I-labelled precursor protein (typically 100 000 cpm; 0.5 µg protein). After 30 min at 37°C, samples were chilled on ice, treated with proteinase K (0.5 mg/ml) for 15 min, precipitated with 7.5 % (mass/vol.) trichloroacetic acid, washed with acetone, dissolved in SDS/PAGE sample buffer, and analysed by 10% SDS/PAGE and autoradiography. Translocation ATPase activity of urea-treated membrane vesicles was measured with preAmyL (10 µg/ml) and B. subtilis SecA (10 µg/ml) as described [41] .
Analytical methods. Protein concentrations were determined by the method of Lowry [42] using BSA as a standard.
RESULTS
Isolation and purification of pre-B-amylase. To develop an in vitro translocation system for the analysis of protein export in B. subtilis, the precursor of the B. licheniformis A-amylase (preAmyL) was isolated. This protein is efficiently secreted by various Bacillus species [43, 44] . A His 6-tag was fused to the aminoterminus of preAmyL to facilitate purification of the precursor form. The gene was placed under control of an isopropylthio-β-D-galactopyranoside-inducible promoter of the E. coli pTRC99a expression vector. Under conditions where protein secretion in E. coli was blocked by the presence of 1 mM azide, large amounts of preAmyL accumulated in inclusion bodies. When the induction was preformed in the absence of azide, preAmyL was processed and secreted as detected by halo formation on starch-containing media (data not shown). The inclusion bodies were extracted with 6 M urea, and the denatured His 6 -tagged preAmyL was purified by Ni ϩ -nitrilotriacetate affinity chromatography (Fig. 1A) . The protein eluted from the column at an imidazole concentration above 100 mM, whereas most contaminants, including the mature AmyL, eluted from the column at lower imidazole concentrations (Fig. 1A) . The presence of the His 6-tag and, thereby, the signal peptide, was confirmed by Western-blot analysis using a polyclonal Ab directed against AmyL (Fig. 1 B, lane 1) and a mAb directed against the His 6 -tag (lane 2). The same method was used to purify the precursor of B. subtilis alkaline phosphatase, prePhoB (Fig. 4 B, lane 3) . Since mature proteins are absent, this method efficiently allows for the purification of urea-denatured precursors to near homogeneity in a single step.
Protease inhibitors are needed for isolation of membrane vesicles containing intact SecY. B. subtilis produces many extracellular proteinases which may pose a major problem for the isolation of membrane vesicles competent of preprotein translocation. To reduce the protease activity, membranes were isolated from B. subtilis strain DB104 that lacks the alkaline proteinase and that is deficient in the neutral proteinase [30] . These combined mutations lead to a protease activity that is reduced to only 2.5 % of the wild-type levels. In addition, the isolation method was optimised for speed. After harvesting, cells were subjected to French pressure cell treatment and membranes were collected by differential centrifugation. After sedimentation of unbroken cells and wall material, membranes were recovered from the supernatant by high-speed centrifugation. The integrity of SecY and SecA was determined by SDS/PAGE and immunoblotting. Although the total preparation time was less than three hours, and despite the use of strain DB104, SecY was completely degraded while SecA appeared stable (Fig. 2, left panel) . The presence of Complete TM , a protease inhibitor cocktail, throughout the membrane vesicle preparation reduced the proteolysis of SecY drastically (Fig. 2, right panel) . When the Marburg strain 168 that produces wild-type levels of extracellular proteinases was used, it was not possible to obtain membrane 1 and 2) , and a polyclonal Ab against SecA (lanes 3 and 4) . SecY and SecA are indicated with an arrow, and the SecY proteolytic fragments are indicated by a bracket. Fig. 3 . Translocation ATPase assay. Urea-treated B. subtilis membrane vesicles were incubated in the presence of 2 mM ATP in the absence or presence of SecA and preAmyL at a concentration of 10 µg/ml each. After incubation for 30 min at 37°C, reactions were stopped by chilling on ice, and the amount of released inorganic phosphate was determined. Standard errors of the mean are of three experiments.
vesicles bearing intact SecY (data not shown). These data demonstrate that the B. subtilis SecY protein is highly susceptible to proteinase digestion, and that intact SecY can only be obtained when proteolysis is efficiently prevented by the use of a proteinase-deficient B. subtilis strain and a general proteinase inhibitor cocktail.
PreAmyL stimulates the SecA translocation ATPase activity.
To assay whether purified His 6 -tagged preAmyL (Fig. 1 B) stimulates the ATP hydrolysis by SecA, membrane vesicles were extracted with urea to inactivate the endogenous SecA and F 0 F 1 -ATPases [33, 45] , and incubated with ATP in the presence or absence of SecA and preAmyL (Fig. 3) . The low level ATPase activity of the urea-treated membrane vesicles (Fig. 3, lane 1) was enhanced upon the addition of B. subtilis SecA (lane 2), and further stimulated by preAmyL. These data demonstrate that the B. subtilis membrane vesicles support the preprotein-stimulated ATPase activity of SecA.
ATP and proton-motive-force-dependent translocation of preAmyL into B. subtilis membrane vesicles. For the translocation studies, preAmyL was iodinated with
125 I. Urea-denatured 125 I-preAmyL (about 5 nM final concentration) was subsequently diluted into a buffer containing native B. subtilis membrane vesicles, and translocation was initiated by the addition of MgATP. After 30 min incubation, translocation was assayed by the amount of proteinase-K-resistant 125 I-preAmyL using SDS/ PAGE and autoradiography. In the presence of ATP, a considerable amount of the 125 I-preAmyL (about 10% added label) became protected for degradation by proteinase (Fig. 4A, lane 2) . When the membrane vesicles (Fig. 4A, lane 1) or ATP (Fig. 5 , lane 1) were omitted from the reaction, no proteinase resistant 125 I-preAmyL was observed. Obviously, the low amount of protease inhibitors still present in the translocation reaction does not interfere with the proteinase K activity. Translocation of preAmyL into the native membrane vesicles was even further stimulated by the addition of purified B. subtilis SecA protein (Fig. 4A, lane 3) . When membrane vesicles were used prepared of strain 168, or of strain DB104 prepared without Complete TM were used, no proteinase-protected preAmyL could be detected (data not shown). These data demonstrate that the B. subtilis membrane vesicles are competent for preAmyL translocation.
To establish further the energy requirement for translocation, experiments were performed with non-hydrolysable ATP analogues and uncouplers that dissipate the proton-motive force. ATP hydrolysis is needed for the reaction, as no proteinase-protected preAmyL was observed when the ATP-dependent reaction was performed in the presence of an excess of the non-hydrolysable ATP analogue, adenosine 5′-[β,γ-imido]triphosphate (AdoPP[NH]P) (Fig. 4A, lanes 4 and 5) . At higher ATP concentration, i.e. 2 mM instead of 2 µM, AdoPP[NH]P was far less efficient as an inhibitor (data not shown). Protein export in B. subtilis strictly requires the proton motive force [16, 17] . The uncoupler (carbonylcyanide p-trifluoromethoxy-phenylhydra- 125 I-PreAmyL translocation reactions were performed with native (A) and urea-treated (B) membrane vesicles of B. subtilis strain DB104 as described in the Materials and Methods. As indicated, reactions were supplemented with purified B. subtilis or E. coli SecA (10 µg/ml) and ATP (2 mM). zone) (CF 3 OPhzC(CN) 2 ; 10 µM) effectively inhibited the ATPdependent preAmyL translocation reaction (Fig. 4A, lane 8 ). An increased concentration of ATP could not relieve the inhibitory effect of CF 3OPhzC (CN)2 (Fig. 4A, lane 10) , but inhibition was efficiently prevented by an excess of purified B. subtilis SecA (lanes 9 and 11). These data suggest that the in vitro translocation reaction exhibits the same energetic requirements as in vivo protein export.
Processing of prePhoB. Due to the diffuse signal caused by the iodine label and the large size of the preAmyL (i.e. 58 kDa), it was not possible to resolve the precursor and mature forms of AmyL on SDS/PAGE. To demonstrate that the membranes actively process translocated precursor, translocation experiments were carried out with B. subtilis prePhoB (Fig. 4 B) .
125 IPrePhoB efficiently translocates (about 30% of input prePhoB) into the B. subtilis inner membrane vesicles in an ATP-dependent manner (data not shown). About 40% of the translocated prePhoB was processed by signal peptidase to the mature PhoB that migrates with a higher mobility on SDS/PAGE (Fig. 4 B,  lane 2 ). The results demonstrate that the translocation activity of the isolated membranes is accompanied by processing of the signal sequence.
Translocation of preAmyL is SecA-dependent. Due to the presence of endogenous SecA, a strict SecA requirement is difficult to demonstrate with native membrane vesicles. Therefore, the effect of azide on the preAmyL translocation was determined. Azide efficiently blocks protein export in E. coli [38] and, at higher concentrations, also in B. subtilis [24, 46] cells. Azide blocks the translocation ATPase activity of SecA [38] and, by preventing hydrolysis of ATP, it traps the SecA in a membrane-inserted state [47] . Addition of 15 mM sodium azide completely inhibited the ATP-dependent translocation of preAmyL into B. subtilis membrane vesicles, both in the absence and presence of an excess of purified SecA protein (Fig. 4 A, lanes 6 and  7) . These data indirectly suggest that preAmyL translocation into B. subtilis membrane vesicles is SecA-dependent.
To establish directly the SecA requirement, experiments with performed with urea-treated membrane vesicles. This treatment inactivates membrane-bound SecA, and renders the translocation reaction in E. coli inner membrane vesicles dependent on the addition of purified SecA [33] . Urea treatment of B. subtilis vesicles completely abolished the translocation activity (compare Fig. 5A and B) . However, addition of purified B. subtilis SecA to these membranes restored translocation only to a low level (Fig. 5 B, lane 4) . In contrast, addition of purified E. coli SecA resulted in a marked stimulation of translocation (Fig. 5 B, lane   6 ), even though it had little effect on the translocation activity of non-urea-treated membrane vesicles (Fig. 5A) . These data suggest that SecA is an essential component of the B. subtilis protein secretion apparatus, but that urea extracts or inactivates other factors that are needed to restore protein translocation to the level found for native membranes.
DISCUSSION
Due to the lack of a functional in vitro protein translocation system, studies on the mechanism of protein secretion in B. subtilis up to now have relied on in vivo pulse-chase experiments. With the in vivo techniques, translocation is usually assayed indirectly by the processing of the preprotein, while for the demonstration of true secretion, more elaborate proteolysis techniques have to be employed which include removal of the cell wall. Another approach of the in vivo studies is that due to the presence of extracellular proteases, degradation of the (partially) translocated proteins occurs [49Ϫ52]. We now have developed an in vitro system for preprotein translocation into B. subtilis membrane vesicles, capable of translocating and processing precursors with an efficiency comparable to that of the E. coli system [33] . This newly described system makes use of purified cytosolic components and preproteins and, thus, can now be used in a systematic manner for the analysis of the functioning and specificity of the translocase of B. subtilis, and its comparative analysis with the well-established E. coli translocase.
One major cause of the inability to functionally reconstitute preprotein translocation from B. subtilis membranes is the high susceptibility of SecY to proteases. Although we have not identified the proteolytic activity responsible for this degradation, it is likely caused by one or more of the secretory proteases. Strain DB104, which lacks the alkaline proteinase and which is deficient in neutral proteinase, still contains a substantial proteolytic activity. SecY was recovered in an intact form when the membrane vesicle isolation procedure was carried out in the presence of the Complete TM protease inhibitor cocktail. Complete TM is a commercial product with an unknown composition, but is particular active against endoproteinases. It is important to note that the Complete TM had to be used at the stage of resuspending the cells and onwards. SecA, the peripheral subunit of the translocase, was recovered in an intact form, irrespective of the use of Complete TM during the membrane isolation protocol. This method may also be useful for the study of other membraneassociated enzymes and processes such as solute transport.
The studies with the B. subtilis membrane vesicles now allow us to establish a number prominent features of the preprotein translocation reaction. Export of proteins from Bacilli has been shown to be sensitive to azide [17, 53] and uncouplers [16, 46] , indicating that hydrolysis of ATP by SecA and the presence of a proton-motive force both are necessary for secretion from B. subtilis, as in the case in E. coli. This is also evident from the in vitro studies. Translocation strictly depends on the hydrolysis of ATP since no translocation is observed in the presence of the non-hydrolysable analog AdoPP[NH]P. Azide, a potent inhibitor of the translocation ATPase activity of SecA, also suppresses translocation, although high concentrations are needed to obtain complete inhibition. Possibly, at low azide concentration, slow hydrolysis of ATP by SecA still enables initiation of translocation. In conjunction with the proton motive force generated by the F 0 F 1 -ATPase, this low level of ATP hydrolysis may suffice efficient translocation. However, care should be taken with high concentrations of azide as this may also block the F 0 F 1 -ATPase, thereby causing a lowering of the proton-motive force. The low-level azide-resistant mutants of E. coli [38] and B. subtilis [46, 53] are confined to the secA (divA) gene. In agreement with the in vivo studies [16] , dissipation of the proton motive force inhibits translocation of preAmyL in vitro. As in E. coli [54] , an excess of purified SecA can overcome this constraint. However, an excess of SecA is unable to compensate for the inhibition by azide. We have recently shown for E. coli SecA that azide interferes with the SecA catalytic cycle [47] , and that it traps the SecYEG-bound SecA in the ATP-occupied conformational state, i.e. the membrane inserted state. Even in the absence of azide, SecA remains trapped in this state and cannot be exchanged for the free cytosolic form of SecA. Obviously, the inhibited SecA occupies the translocation sites and, thereby, prevents the initiation of new translocation events. The data on the azide inhibition of preAmyL translocation into B. subtilis membrane vesicles are consistent with a catalytic involvement of SecA.
Direct evidence of a requirement for SecA is provided by the studies with urea-treated vesicles. Urea removes and inactivates peripheral membrane proteins, and with E. coli inner membranes, translocation becomes dependent on the addition of purified SecA after urea treatment [33] . However, in order to restore preprotein translocation to the level observed with native membrane vesicles, the ability to generate a proton-motive force also has to be restored [55] . Urea treatment seems to have a similar effect on B. subtilis membrane vesicles. Translocation is completely abolished and can only be partially restored by the addition of purified B. subtilis SecA. Strikingly, the E. coli SecA restores translocation into urea-treated membranes to a substantial level. A mechanistic explanation for this phenomena cannot yet be given, and will require further investigations. For instance, it could be that the lack of a proton motive force is more harmful when the B. subtilis SecA is used than the E. coli protein. In E. coli, SecA has been shown to suppress the protonmotive-force dependency of preprotein translocation [54] , but the exact mechanism has not yet been resolved. Studies with native membrane vesicles show that preAmyL translocation is strongly dependent on the proton-motive force. A more detailed study on the proton-motive force dependency of the translocation of preAmyL variants is in progress.
Our in vitro experiments do not strictly require the presence of a chaperone. A subset of preproteins in E. coli is dependent on the molecular chaperone SecB for in vivo and in vitro translocation [34, 56, 57] . Under certain conditions, other chaperones such as GroESL or DnaK/DnaJ/GrpE may support translocation [58Ϫ60]. However, unlike SecB, these chaperones have no targeting role. From B. subtilis, no data is available that would indicate that chaperones are needed to support protein secretion, and the B. subtilis chromosome does not appear to harbor a gene that codes for a SecB homologue which shows significant similarity to the E. coli enzyme [14] . When co-expressed in B. subtilis, E. coli secB supports the translocation of maltose-binding protein [61] . The SecB-binding domain of the E. coli SecA is confined to the carboxyl-terminal 22 amino acids [62] . This region, which is critical for the targeting function of SecB, is highly conserved among bacterial SecA proteins and is also present in the B. subtilis SecA. We have recently observed that the carboxyl-terminus of the B. subtilis SecA is able to bind SecB (Van Wely, K., unpublished results), consistent with the ability of B. subtilis SecA to support the SecB function in vivo [61] and in vitro (this data). Therefore, it will be important to determine if the carboxyl-terminus of SecA fulfills a rudimentary function or if it is involved in the binding of a cytosolic chaperone that has a similar function, but different structure to the E. coli SecB.
In conclusion, we have developed an in vitro system for the study of preprotein translocation in B. subtilis. Translocation of purified and urea-denaturated preAmyL is dependent on SecA and is driven by the hydrolysis of ATP and by the proton-motive force. The in vitro system opens a new area in the study of preprotein translocation in Bacilli and can be a useful tool to identify components of the protein-secretion machinery that, up to now, have been unknown in B. subtilis, such as functional homologues of the E. coli SecG and SecB, and possibly other novel components. These studies may provide new leads in the optimisation of the secretion of heterologous proteins, and will be useful for comparative purposes with the paradigm secretory system of E. coli.
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